News

Anthropic has long been warning about these risks—so much so that in 2023, the company pledged to not release certain models ...
The sole faculty union at the University of Oregon has declared itself a “sanctuary union” that will not cooperate with ...
Republicans in the House of Representatives introduced the One, Big, Beautiful Bill of 2025 (the “House Bill”). The House Bill ...
Let’s be honest: no founder wakes up thinking, “Today, I’ll optimize my email signature and digital business card!” ...
This browser is no longer supported at MarketWatch. For the best MarketWatch.com experience, please update to a modern browser.
Countouriotis is the founder of Avenzo Therapeutics, Inc. since 2022, holding the title of President, Chief Executive & Financial Officer. Current jobs include Chairman at Recludix Pharma, Inc. since ...
Italy's Constitutional Court has ruled that two women can register as parents of a child on a birth certificate, saying recognition of parental rights cannot be restricted to the biological mother in ...
The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials.
It's all so predictable. Every time the internet focuses in on yet another rebranding catastrophe, certain voices on social ...
Researchers have identified genetic variants in the FOXP4 gene that significantly increase the risk of developing long COVID, ...
Imagine drawing on something as delicate as a living cell—without damaging it. Researchers at the University of Missouri have ...
When it comes to efficacious, hard-working skincare products, we’re spoilt for choice. A quick browse through any beauty ...